Search Results - "Luikart, H."

The role of complement‐fixing donor‐specific antibodies identified by a C1q assay after heart transplantation by Farrero Torres, M., Pando, M.J., Luo, C., Luikart, H., Valantine, H., Khush, K.

“…Background The development of donor‐specific antibodies (DSA) to human leukocyte antigens (HLA) has been associated with acute rejection and allograft failure…”
Get full text

Outcomes of ISHLT Lung Transplant AMR by Cochrane, A.B., Levine, D., Ponor, I., Philogene, M., Jang, M., Tunc, I., Mathew, J., Luikart, H., Shah, P., Khush, K., Marboe, C., Berry, G., Valentine, H., Agbor-Enoh, S.

“…ISHLT published diagnostic criteria for AMR in 2016 delineating the diagnostic certainty of AMR with definite, probable, and possible grading that considers…”
Get full text

Association of Heart Transplant Recipient Age and Body Mass Index with Microcirculatory Remodeling by Cohen, G, Strehl, C, Luikart, H, Fearon, W.F, Khush, K

Get full text

Early and Late Pulmonary AMR Show Distinct Profiles; Clinical and Epigenetic Analyses by Agbor-Enoh, S., Jang, M., Singh, K., Tunc, I., Pirooznia, M., Seifuddin, F., Ponor, I., Levine, D., Cochrane, A., Philogene, M., Mathews, J., Shah, P., Luikart, H., Khush, K.K., Marboe, C., Berry, G., Valantine, H.

“…Antibody-Mediated Rejection (AMR) that occurs latter in the lung transplant (LTx) course show greater risk of chronic lung allograft dysfunction (CLAD) than…”
Get full text

Allograft Injury and Outcomes in African American Lung Transplant Recipients by Agbor-Enoh, S., Charya, A., Jang, M., Luikart, H., Shah, P., Matthews, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Bhatti, K., Marishta, A., Yang, Y., Tunc, I., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K., Orens, J.B., Valantine, H.

“…African American patients (AA) have poorer outcomes than White patients (W) after heart and kidney transplant. Little is known about differential outcomes in…”
Get full text

Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction by Keller, M.B., Shah, P., Bush, E., Diamond, J.M., Matthews, J., Brown, A.W., Timofte, I., Fideli, U.S., Kong, H., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Luikart, H., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valentine, H.A., Agbor-Enoh, S.

“…Primary Graft Dysfunction (PGD) is a risk factor for Chronic Lung Allograft Dysfunction (CLAD). However, this association requires further examination for…”
Get full text

Lung Transplantation: DSA to AMR Trajectory by Ponor, I., Levine, D., Cochrane, A., Philogene, M.C., Shah, P.D., Mathew, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Marishta, A., Yang, Y., Tunc, I., Luikart, H., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valentine, H., Agbor-Enoh, S.

“…Donor specific antibodies(DSA) are a major risk factor for antibody mediated rejection (AMR) and allograft failure in lung transplant recipients (LTs). The…”
Get full text

To Treat or Not to Treat: DSA Positive Lung Transplant Recipients by Agbor-Enoh, S., Ponor, I., Shah, P., Levine, D., Cochrane, A., Philogene, M., Matthews, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Marishta, A., Bhatti, K., Tunc, I., Yang, Y., Luikart, H., Marboe, C., Berry, G., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valantine, H.

“…Donor-specific antibodies (DSA) is a major risk factor for chronic lung allograft dysfunction (CLAD) after lung transplantation (LTx). Unfortunately, DSA…”
Get full text

Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients by Agbor-Enoh, S, Tunc, I, De Vlaminck, I, Davis, A, Gorham, S, Jang, M, Cuttin, K, Fideli, U, Marishta, A, Wylie, J, Luikart, H, Khush, K, Valantine, H

Get full text

Donor-Derived Cell-Free DNA Associates with Rejection in Lung Transplantation Using Clinical-Grade Targeted Next-Generation Sequencing by Khush, K.K, Beausang, J.F, Woodward, R.N, Lew, D, Sninsky, J, De Vlaminck, I, Strehl, C, Luikart, H, Nicolls, M, Weill, D

Get full text

Pioglitazone for the Treatment of Insulin Resistance in Heart Transplant Recipients: Assessment of Efficacy and Safety by Ray, R, Shih, M, Constantz, N, Kohli, B, Luikart, H, Khush, K

Get full text

Circulating Cell-Free DNA as a Non-Invasive Marker of Pediatric Heart Transplant Rejection and Immunosuppressive Treatment by Khush, K.K, Grskovic, M, Luikart, H, Cohen, G, Strehl, C, Wylie, J, Thompson, K, Christie, B, Collins, J, Hiller, D, Yee, J, Bernstein, D

Get full text

Quality of Life and Metrics of Achievement in Long-Term Adult Survivors of Pediatric Heart Transplant by Hollander, S.A, Chen, S, Luikart, H, Burge, M, Rosenthal, D.N, Maeda, K, Hunt, S.A, Bernstein, D

Get full text

Circulating Cell-Free DNA Is a Non-Invasive Marker of Heart Transplant Rejection by De Vlaminck, I, Valantine, H.A, Luikart, H, Weisshaar, D, Bernstein, D, Quake, S.R, Khush, K.K

Get full text

Non-Invasive Monitoring of Infection and Rejection After Lung Transplantation by Vlaminck, I.D, Martin, L, Kertesz, M, Patel, K.N, Kowarsky, M, Strehl, C, Cohen, G, Luikart, H, Neff, N, Okamoto, J, Nicolls, M.N, Cornfield, D.N, Weill, D, Valantine, H.A, Khush, K.K, Quake, S.R

Get full text

(507) Leukotriene B4 Mediates Development of Cardiac Allograft Vasculopathy after Heart Transplantation by Khush, K., Wang, D., Luikart, H., Kim, D., Schrepfer, S.

“…The mechanisms underlying the development of cardiac allograft vasculopathy (CAV), the leading cause of long-term graft failure and mortality after heart…”
Get full text

494: Changing Trends in Infectious Complications among Heart Transplant Recipients by Haddad, F, Deuse, T, Rosso, F, Pham, M, Khazanie, P, Luikart, H, Valantine, H.A, Hunt, S.A, Vu, T, Oyer, P.E, Robbins, R.C, Montoya, J.G

Get full text

(1398) - Challenging the Conventional Wisdom of Apixaban Dose Adjustments in Heart Transplants on Posaconazole with and without Dialysis by Lee, R., Henricksen, E., Kim, D., Luikart, H., Moayedi, Y., Teuteberg, J., Khush, K.

Get full text

(141) - Young at Heart: Survival Among Septuagenarian Heart Transplant Recipient Has Decreased Over the Past Decade by Henricksen, E., Wayda, B., Teuteberg, J., Luikart, H., Njoroge, J., Guenthart, B., Khush, K.

Get full text

(142) - Just a Number? Donor Age and (Lack of) Associated Reasons for Heart Offer Refusal in the Donor Heart Study by Bhowmik, C., Wayda, B., Luikart, H., Weng, Y., Zhang, S., Wood, R.P., Nieto, J., Groat, T., Neidlinger, N., Khush, K.K.

Get full text